Temporal trends and patterns in percutaneous treatment of coronary artery disease in Poland in the years 2005–2011

Abstract

Use of modern attributes of interventional cardiology like DES stents, radial approach, and treatment of higher risk patients has increased in Poland in 2005-2011. The adoption of the "Stent for Life" initiative has resulted in an increasing number of percutaneous coronary procedures over the years.

Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study

“…According to the EPICOR study, abciximab was used in this setting in 37.8% of STEMI patients, and eptifibatide in 7.9%. Comparing this same data in a summary report of the Association of Cardiovascular Interventions of the PCS, the use of GPIIb/IIIa in 2011 was: eptifibatide -58% and abciximab -41% (relative value) [2,12].…”

“…At the time when the EPICOR study was conducted, there were 140 cath labs in Poland. From 2002 to 2012 the number of coronary angiography procedures in Poland was 217,126 and the number of coronary angioplasty procedures was 119,746 [2,12,13]. However, the system of transfer of patients initially admitted to hospitals without cath labs needs to be time-optimised because in these cases the first medical contact -balloon time is significantly longer than, for example, in Germany [14].…”

“…In Poland, there are currently two ongoing national registries: PL-ACS (including the whole spectrum of ACS patients treated either invasively or non-invasively) and the Polish National PCI Registry (only patients treated with percutaneous interventions). Annual reports from the latter are published each year by the Polish Association of Cardiovascular Interventions of the Polish Cardiac Society (PCS) [12,13]. Detailed reporting of invasive procedures in all active invasive cardiology centres and managed at a national level by the PCS has resulted in data on almost 1.5 million catheterisations and PCIs over a period of seven calendar years (2005-2011).…”

Coronary Catheterization and Percutaneous Coronary Intervention in China

“…12,35–38 This finding may be associated with differences in case selection wherein patients at highest risk of adverse outcomes were not undergoing PCI. In China, many patients with STEMI do not received timely revascularization, 33 and in our study, the proportions of patients with cardiac arrest or cardiogenic shock were lower than those reported in the United States.…”

New model of secondary cardiovascular prevention for patients after acute coronary syndromes in Poland with regard to Norwegian experiences

“…The well-planned development and organisation of invasive cardiology in the last two decades has brought Poland to the third place in Europe in terms of number of primary PCI in ST elevation myocardial infarction (STEMI) per million inhabitants per year and has led to the fulfilment of all criteria required by the "Stent for Life" initiative [3]. The quality of percutaneous treatment of patients in Poland has improved and grown in numbers, and has followed international trends in the adoption of modern PCI techniques and utilisation of novel devices and medications [4]. Nevertheless, the incidence rates of new onset myocardial infarction (MI) are still higher in Poland than in Western Europe [5,6].…”